Literature DB >> 33662018

Polymorphic SERPINA3 prolongs oligomeric state of amyloid beta.

Maruf Mohammad Akbor1, Nobuyuki Kurosawa1, Hiroki Nakayama1, Ayumi Nakatani1, Koji Tomobe2, Yoichi Chiba3, Masaki Ueno3, Masashi Tanaka4, Yasuyuki Nomura5, Masaharu Isobe1.   

Abstract

Molecular chaperon SERPINA3 colocalizes with accumulated amyloid peptide in Alzheimer's disease (AD) patient's brain. From the QTL analysis, we narrowed down Serpina3 with two SNPs in senescence-accelerated mouse prone (SAMP) 8 strain. Our study showed SAMP8 type Serpina3 prolonged retention of oligomeric Aβ 42 for longer duration (72 hr) while observing under transmission electron microscope (TEM). From Western blot results, we confirmed presence of Aβ 42 oligomeric forms (trimers, tetramers) were maintained for longer duration only in the presences of SAMP8 type Serpina3. Using SH-SY5Y neuroblastoma cell line, we observed until 36 hr preincubated Aβ 42 with SAMP8 type Serpina3 caused neuronal cell death compared to 12 hr preincubated Aβ 42 with SAMR1 or JF1 type Serpina3 proteins. Similar results were found by extending this study to analyze the effect of polymorphism of SERPINA3 gene of the Japanese SNP database for geriatric research (JG-SNP). We observed that polymorphic SERPINA3 I308T (rs142398813) prolonged toxic oligomeric Aβ 42 forms till 48 hr in comparison to the presence wild type SERPINA3 protein, resulting neuronal cell death. From this study, we first clarified pathogenic regulatory role of polymorphic SERPINA3 in neurodegeneration.

Entities:  

Year:  2021        PMID: 33662018      PMCID: PMC7932536          DOI: 10.1371/journal.pone.0248027

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  63 in total

1.  Alpha-1 antichymotrypsin and alpha-2 macroglobulin gene polymorphisms are not associated with Korean late-onset Alzheimer's disease.

Authors:  C S Ki; D L Na; H J Kim; J W Kim
Journal:  Neurosci Lett       Date:  2001-04-20       Impact factor: 3.046

Review 2.  Epigenetic inheritance associated with human chromosome 14.

Authors:  D Kamnasaran
Journal:  Clin Invest Med       Date:  2001-06       Impact factor: 0.825

Review 3.  Molecular genetics of late-onset Alzheimer's disease.

Authors:  M Ilyas Kamboh
Journal:  Ann Hum Genet       Date:  2004-07       Impact factor: 1.670

Review 4.  Soluble Aβ oligomer production and toxicity.

Authors:  Megan E Larson; Sylvain E Lesné
Journal:  J Neurochem       Date:  2011-11-28       Impact factor: 5.372

5.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

6.  Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice.

Authors:  L Mucke; G Q Yu; L McConlogue; E M Rockenstein; C R Abraham; E Masliah
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

7.  Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers.

Authors:  Matthew Townsend; Ganesh M Shankar; Tapan Mehta; Dominic M Walsh; Dennis J Selkoe
Journal:  J Physiol       Date:  2006-02-09       Impact factor: 5.182

8.  Modifiable Risk Factors for Alzheimer's Disease.

Authors:  George A Edwards Iii; Nazaret Gamez; Gabriel Escobedo; Olivia Calderon; Ines Moreno-Gonzalez
Journal:  Front Aging Neurosci       Date:  2019-06-24       Impact factor: 5.750

9.  Genome-wide association study of Alzheimer's disease.

Authors:  M I Kamboh; F Y Demirci; X Wang; R L Minster; M M Carrasquillo; V S Pankratz; S G Younkin; A J Saykin; G Jun; C Baldwin; M W Logue; J Buros; L Farrer; M A Pericak-Vance; J L Haines; R A Sweet; M Ganguli; E Feingold; S T Dekosky; O L Lopez; M M Barmada
Journal:  Transl Psychiatry       Date:  2012-05-15       Impact factor: 6.222

10.  Postsynaptic Proteome of Non-Demented Individuals with Alzheimer's Disease Neuropathology.

Authors:  Olga Zolochevska; Nicole Bjorklund; Randall Woltjer; John E Wiktorowicz; Giulio Taglialatela
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more
  1 in total

1.  Elucidation of the neurological effects of clothianidin exposure at the no-observed-adverse-effect level (NOAEL) using two-photon microscopy in vivo imaging.

Authors:  Misaki Nishi; Shouta Sugio; Tetsushi Hirano; Daisuke Kato; Hiroaki Wake; Asuka Shoda; Midori Murata; Yoshinori Ikenaka; Yoshiaki Tabuchi; Youhei Mantani; Toshifumi Yokoyama; Nobuhiko Hoshi
Journal:  J Vet Med Sci       Date:  2022-03-10       Impact factor: 1.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.